These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33065064)

  • 21. Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease.
    Rahier JF; Yazdanpanah Y; Viget N; Travis S; Colombel JF
    Aliment Pharmacol Ther; 2010 Jan; 31(1):5-10. PubMed ID: 19814744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lightning fast development of pandemic vaccines in 2020].
    Josefsdottir KS
    Laeknabladid; 2020 Dec; 106(12):567. PubMed ID: 33252047
    [No Abstract]   [Full Text] [Related]  

  • 23. SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.
    Siegel CA; Melmed GY; McGovern DP; Rai V; Krammer F; Rubin DT; Abreu MT; Dubinsky MC; ;
    Gut; 2021 Apr; 70(4):635-640. PubMed ID: 33472895
    [No Abstract]   [Full Text] [Related]  

  • 24. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
    Mamula P; Markowitz JE; Piccoli DA; Klimov A; Cohen L; Baldassano RN
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):851-6. PubMed ID: 17544875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza vaccines in patients with IBD: ready for primetime?
    Kunisaki KM
    Gut; 2011 Apr; 60(4):433-4. PubMed ID: 21270120
    [No Abstract]   [Full Text] [Related]  

  • 26. Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients.
    Hua C; Morel J; Ardouin E; Ricard E; Foret J; Mathieu S; Combe B; Lukas C
    Rheumatology (Oxford); 2015 Apr; 54(4):748-50. PubMed ID: 25667433
    [No Abstract]   [Full Text] [Related]  

  • 27. Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey.
    Crispino F; Brinch D; Carrozza L; Cappello M
    Inflamm Bowel Dis; 2021 Oct; 27(11):e134-e135. PubMed ID: 34089256
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety of Drugs During Previous and Current Coronavirus Pandemics: Lessons for Inflammatory Bowel Disease.
    Sebastian S; Gonzalez HA; Peyrin-Biroulet L
    J Crohns Colitis; 2020 Nov; 14(11):1632-1643. PubMed ID: 32520312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance.
    Auriel E; Regev K; Dori A; Karni A
    Muscle Nerve; 2011 Jun; 43(6):893-4. PubMed ID: 21607970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between Covid-19 Vaccination and Influenza Vaccination Rates.
    Leuchter RK; Jackson NJ; Mafi JN; Sarkisian CA
    N Engl J Med; 2022 Jun; 386(26):2531-2532. PubMed ID: 35704429
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ideal vaccination strategy in inflammatory bowel disease].
    Lee CK
    Korean J Gastroenterol; 2015 Mar; 65(3):159-64. PubMed ID: 25797379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updates on vaccinating the inflammatory bowel disease patient.
    Zullow S; Farraye FA
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):229-239. PubMed ID: 30791761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccines and recommendations for their use in inflammatory bowel disease.
    Sánchez-Tembleque MD; Corella C; Pérez-Calle JL
    World J Gastroenterol; 2013 Mar; 19(9):1354-8. PubMed ID: 23538680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinating the inflammatory bowel disease patient.
    Desalermos AP; Farraye FA; Wasan SK
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):91-102. PubMed ID: 25160668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How COVID unlocked the power of RNA vaccines.
    Dolgin E
    Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
    [No Abstract]   [Full Text] [Related]  

  • 36. Doctor-Should I get the COVID-19 vaccine? Infection and immunization in individuals with neuromuscular disorders.
    Živković SA; Gruener G; Narayanaswami P;
    Muscle Nerve; 2021 Mar; 63(3):294-303. PubMed ID: 33471383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?
    Reich JS; Farraye FA; Wasan SK
    Dig Dis Sci; 2016 Aug; 61(8):2205-2216. PubMed ID: 27061291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial.
    deBruyn J; Fonseca K; Ghosh S; Panaccione R; Gasia MF; Ueno A; Kaplan GG; Seow CH; Wrobel I
    Inflamm Bowel Dis; 2016 Mar; 22(3):638-47. PubMed ID: 26595551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement.
    Bhugra P; Grandhi GR; Mszar R; Satish P; Singh R; Blaha M; Blankstein R; Virani SS; Cainzos-Achirica M; Nasir K
    J Am Heart Assoc; 2021 Aug; 10(15):e019671. PubMed ID: 34315229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review on medical management of inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Chela H; Pasha SB; Wan XF; Ghouri YA
    J Gastroenterol Hepatol; 2021 Apr; 36(4):918-926. PubMed ID: 32876952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.